Piette, J. D. & Kerr, E. A. The impact of comorbid chronic conditions on diabetes care. Diabetes Care 29, 725–731 (2006).
Schabert, J., Browne, J. L., Mosely, K. & Speight, J. Social stigma in diabetes. PATIENT 6, 1–10 (2013).
Zimmet, P. Z. Diabetes epidemiology as a tool to trigger diabetes research and care. Diabetologia 42, 499–518 (1999).
International Diabetes Federation. IDF Diabetes Atlas, 9th ed. https://www.diabetesatlas.org/en/resources/ (2020).
Alonso-Morán, E. et al. Multimorbidity in people with type 2 diabetes in the Basque Country (Spain): prevalence, comorbidity clusters and comparison with other chronic patients. Eur. J. Intern. Med. 26, 197–202 (2015).
Roy, T. & Lloyd, C. E. Epidemiology of depression and diabetes: a systematic review. J. Affect. Disord. 142(Suppl), S8–S21 (2012).
Taback, S. P., Freedland, K. E., Clouse, R. E. & Lustman, P. J. Controlled trials of HbA1c measurements. Diabetes Care 23, 434–435 (2000).
Ali, S. et al. The association between depression and health-related quality of life in people with type 2 diabetes: a systematic literature review. Diabetes Metab. Res. Rev. 26, 75–89 (2010).
Cols-Sagarra, C. et al. Prevalence of depression in patients with type 2 diabetes attended in primary care in Spain. Prim. Care Diabetes 10, 369–375 (2016).
Nicolau, J. et al. Prevalence and clinical correlators of undiagnosed significant depressive symptoms among individuals with type 2 diabetes in a Mediterranean population. Exp. Clin. Endocrinol. Diabetes 124, 630–636 (2016).
Kimbro, L. B. et al. Depression and all-cause mortality among persons with diabetes: are older adults at higher risk? Results from the Translating Research into Action for Diabetes (TRIAD) Study. J. Am. Geriatr. Soc. 18, 1199–1216 (2013).
Chima, C. C. et al. Multimorbidity is associated with increased rates of depression in patients hospitalized with diabetes mellitus in the United States. J. Diabetes Complic. 31, 1571–1579 (2017).
Sun, N. et al. Prevalence and determinants of depressive and anxiety symptoms in adults with type 2 diabetes in China: a cross-sectional study. BMJ Open 6, e012540. https://doi.org/10.1136/bmjopen-2016-012540 (2016).
World Health Organization. Depression and other common mental disorders. https://www.who.int/mental_health/management/depression/prevalence_global_health_estimates/en/ (2017).
Gonzalez, J. Depression in The American Diabetes Association/JDRF Type 1 Diabetes Sourcebook (eds. Peters, A. & Laffel, L.), 169–179 (2013).
Egede, L. E., Zheng, D. & Simpson, K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care 25, 464–470 (2002).
Ducat, L., Philipson, L. H. & Anderson, B. J. The mental health comorbidities of diabetes. JAMA 312, 691–692 (2014).
Lynch, C. P., Gebregziabher, M., Zhao, Y., Hunt, K. J. & Egede, L. E. Impact of medical and psychiatric multi-morbidity on mortality in diabetes: emerging evidence. BMC Endocr. Disord. 14, 68. https://doi.org/10.1186/1472-6823-14-68 (2014).
Walker, E. R., McGee, R. E. & Druss, B. G. Mortality in mental disorders and global disease burden implications. JAMA Psychiatry 72, 334 (2015).
Park, M., Katon, W. J. & Wolf, F. M. Depression and risk of mortality in individuals with diabetes: a meta-analysis and systematic review. Gen. Hosp. Psychiatry 35, 217–225 (2013).
Reisinger Walker, E., McGee, R. E. & Druss, B. G. Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry 72, 334–341 (2015).
Anderson, R. J., Freedland, K. E., Clouse, R. E. & Lustman, P. J. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24, 1069–1078 (2001).
Polonsky, W. H. et al. Assessment of diabetes-related distress. Diabetes Care 18, 754–760 (1995).
Polonsky, W. H. et al. Assessing psychosocial distress in diabetes: development of the Diabetes Distress Scale. Diabetes Care 28, 626–631 (2005).
Perrin, N. E., Davies, M. J., Robertson, N., Snoek, F. J. & Khunti, K. The prevalence of diabetes-specific emotional distress in people with type 2 diabetes: a systematic review and meta-analysis. Diabet. Med. 34, 1508–1520 (2017).
Dennick, K., Sturt, J. & Speight, J. What is diabetes distress and how can we measure it? A narrative review and conceptual model. J. Diabetes Complic. 31, 898–911 (2017).
Rubin, R. R. & Peyrot, M. Psychological issues and treatments for people with diabetes. J. Clin. Psychol. 57, 457–478 (2001).
Smith, K. J., Deschênes, S. S. & Schmitz, N. Investigating the longitudinal association between diabetes and anxiety: a systematic review and meta-analysis. Diabet. Med. 35, 677–693 (2018).
Ali, S., Stone, M. A., Peters, J. L., Davies, M. J. & Khunti, K. The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabet. Med. 23, 1165–1173 (2006).
Golden, S. H. et al. Examining a bidirectional association between depressive symptoms and diabetes. JAMA 299, 2751–2759 (2008).
Mezuk, B., Eaton, W. W., Albrecht, S. & Golden, S. H. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 31, 2383–2390 (2008).
Rotella, F. & Mannucci, E. Depression as a risk factor for diabetes: a meta-analysis of longitudinal studies. J. Clin. Psychiatry 74, 31–37 (2013).
Rotella, F. & Mannucci, E. Diabetes mellitus as a risk factor for depression. A meta-analysis of longitudinal studies. Diabetes Res. Clin. Pract. 99, 98–104 (2013).
Demakakos, P., Zaninotto, P. & Nouwen, A. Is the association between depressive symptoms and glucose metabolism bidirectional? Evidence from the English longitudinal study of ageing. Psychosom. Med. 76, 555–561 (2014).
Nouwen, A. et al. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia 53, 2480–2486 (2010).
Yu, M., Zhang, X., Lu, F. & Fang, L. Depression and risk for diabetes: a meta-analysis. Can. J. Diabetes 39, 266–272 (2015).
Demakakos, P., Muniz-Terrera, G. & Nouwen, A. Type 2 diabetes, depressive symptoms and trajectories of cognitive decline in a national sample of community-dwellers: a prospective cohort study. PLoS One 12, e0175827. https://doi.org/10.1371/journal.pone.0175827 (2017).
Farooqi, A. et al. Comorbid depression and risk of cardiac events and cardiac mortality in people with diabetes: a systematic review and meta-analysis. Diabetes Res. Clin. Pract. 156, 107816. https://doi.org/10.1016/j.diabres.2019.107816 (2019).
Möller-Leimkühler, A. M. Gender differences in cardiovascular disease and comorbid depression. Dialogues Clin. Neurosci. 9, 71–83 (2007).
Hazuda, H. P. et al. Long-term association of depression symptoms and antidepressant medication use with incident cardiovascular events in the look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in type 2 diabetes. Diabetes Care 42, 910–918 (2019).
Katon, W., Maj, M. & Sartorius, N. Depression and Diabetes (Wiley, Hoboken, 2010).
Sardinha, A. & Nardi, A. E. The role of anxiety in metabolic syndrome. Expert Rev. Endocrinol. Metab. 7, 63–71 (2012).
Hasan, S. S., Clavarino, A. M., Dingle, K., Mamun, A. A. & Kairuz, T. Diabetes mellitus and the risk of depressive and anxiety disorders in australian women: a longitudinal study. J. Women’s Heal. 24, 889–898 (2015).
Edwards, L. E. & Mezuk, B. Anxiety and risk of type 2 diabetes: evidence from the Baltimore Epidemiologic Catchment Area Study. J. Psychosom. Res. 73, 418–423 (2012).
Smith, S. M., Wallace, E., O’Dowd, T. & Fortin, M. Interventions for improving outcomes in patients with multimorbidity in primary care and community settings. Cochrane Database Syst. Rev. 14, 006560. https://doi.org/10.1002/14651858.CD006560.pub3 (2016).
Anderson, R. J. et al. Anxiety and poor glycemic control: a meta-analytic review of the literature. Int. J. Psychiatry Med. 32, 235–247 (2002).
Balhara, Y. P. S. & Sagar, R. Correlates of anxiety and depression among patients with type 2 diabetes mellitus. Indian J. Endocrinol. Metab. 15, 50. https://doi.org/10.4103/2230-8210.83057 (2011).
Jansson-Fröjmark, M. & Lindblom, K. A bidirectional relationship between anxiety and depression, and insomnia? A prospective study in the general population. J. Psychosom. Res. 64, 443–449 (2008).
Oficina de las Naciones Unidas contra la Droga y el Delito. Resumen ejecutivo – Informe Mundial sobre las Drogas 2016; https://www.unodc.org/doc/wdr2016/WDR_2016_ExSum_spanish.pdf (2016).
Walter, K. N., Wagner, J. A., Cengiz, E., Tamborlane, W. V. & Petry, N. M. Substance use disorders among patients with type 2 diabetes: a dangerous but understudied combination. Curr. Diab. Rep. 17, 1–13 (2017).
Holt, R. I. G. Diagnosis, epidemiology and pathogenesis of diabetes mellitus: an update for psychiatrists. Br. J. Psychiatry 47, S55–S63 (2004).
Hoffman, R. P. The complex inter-relationship between diabetes and schizophrenia. Curr. Diabetes Rev. 13, 528–532 (2017).
Brink, M. et al. Excess medical comorbidity and mortality across the lifespan in schizophrenia: a nationwide Danish register study. Schizophr. Res. 206, 347–354 (2019).
Mamakou, V., Thanopoulou, A., Gonidakis, F., Tentolouris, N. & Kontaxakis, V. Schizophrenia and type 2 diabetes mellitus. Psychiatrike 29, 64–73 (2018).
Agency for Healthcare Research and Quality. Guide to prevention quality indicators: hospital admission for ambulatory care sensitive conditions. https://www.ahrq.gov/downloads/pub/ahrqqi/pqiguide.pdf (Agency for Healthcare Research and Quality, 2001).
Muth, C. et al. The Ariadne principles: how to handle multimorbidity in primary care consultations. BMC Med. 12, 1–11 (2014).
Prados-Torres, A. et al. Cohort profile: the epidemiology of chronic diseases and multimorbidity. The EpiChron Cohort Study. Int. J. Epidemiol. 47, 382–384 (2018).
The Johns Hopkins University. Johns Hopkins ACG System. https://www.hopkinsacg.org/. (2018).
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 5th edn. (American Psychiatric Publishing, Washington, 2013).
Salisbury, C., Johnson, L., Purdy, S., Valderas, J. M. & Montgomery, A. A. Epidemiology and impact of multimorbidity in primary care: a retrospective cohort study. Br. J. Gen. Pract. 61, e12-21 (2011).